Showing results (211-220 of 326) with videos related to
Sort By:
Pageof 33
The Lancet. Oncology|June 7, 2017
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworksJoseph C Del Paggio, Richard Sullivan, Deborah Schrag, et al.The Oncologist|October 28, 2023
Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in RwandaFidel Rubagumya, Brooke Wilson, Achille Manirakiza, et al.JCO Global Oncology|February 23, 2023
Patient Satisfaction With Breast Cancer Care Delivery at the National Cancer Institute of Sri Lanka: Does Language Play a Role?Susan J Thanabalasingam, Sarith S Ranawaka, Sathika S C Gunarathna, et al.Urologic Oncology|July 23, 2015
Outcomes of squamous histology in bladder cancer: a population-based studyJason P Izard, D Robert Siemens, William J Mackillop, et al.Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and EnablersMelanie Walker, R Christopher Doiron, Simon D French, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 5, 2017
Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablersMelanie Walker, Simon D French, R Christopher Doiron, et al.Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.Current Oncology (Toronto, Ont.)|April 30, 2021
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled TrialsShubham Sharma, J Connor Wells, Wilma M Hopman, et al.Journal of Pain and Symptom Management|January 3, 2017
Civil Society-Driven Drug Policy Reform for Health and Human Welfare-IndiaNandini Vallath, Tripti Tandon, Tania Pastrana, et al.JCO Global Oncology|June 17, 2021
Tracking the Workforce 2020-2030: Making the Case for a Cancer Workforce RegistryArchita Srivastava, Matthew Jalink, Fabio Ynoe de Moraes, et al.Pageof 33